Delivery Order SPE2DB22D3401-SPE2DB25FT1XU

Award Date 2/4/25
Potential Completion Date 2/5/25
Potential Value $5.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, with a ceiling value of $1,064.70 and a completion date of February 24, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, with a ceiling value of $1,844.56 and a completion date of June 5, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This federal contract award is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a medication, with a Ceiling Value of $5,115.99 and a period of performance through January 24, 2025. The contract is a Firm Fixed Price instrument and does not have a set-aside designation, indicating open competition....
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,657.95, is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product. The contract has a period of performance through February 5, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award, valued at $1,927.80, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, with a completion date of December 6, 2024. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC)...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML pharmaceutical products. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $4,815.32 and a completion date of December 18, 2024. The contract is not designated as a set-aside and has been awarded directly to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution and healthcare solutions provider....
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, and has a ceiling value of $11,264.70. The contract is a delivery order with a firm fixed price type and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a migraine medication. The contract has a Firm Fixed Price of $1,407.36 and an ultimate completion date of November 14, 2024. This Delivery Order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, with a ceiling value of $7,928.87, is for the delivery of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 15, 2023. The award was made on December 14, 2022 and is not designated...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,072.34 firm fixed-price delivery order is for the supply of AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, a pharmaceutical product, with a period of performance through November 18, 2024. The award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
  • SPE2DB22D3401
    Indefinite Delivery Contract
  • SPE2DB22D3401-SPE2DB25FT1XU
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of medical products, specifically 4567156460 AJOVY 225 MG/1.5 ML AUTOINJECT 1.5ML, with a ceiling value of $5,091.21 and a completion date of February 5, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award does not have a set-aside designation, indicating open competition.

Generated 5/21/25, 10:08 AM